Cervical Adenocarcinoma, also known as adenocarcinoma of the uterine cervix, is related to cervical mucinous adenocarcinoma and wolffian duct adenocarcinoma. An important gene associated with Cervical Adenocarcinoma is CDKN2A (Cyclin Dependent Kinase Inhibitor 2A), and among its related pathways/superpathways are ERK Signaling and Signal Transduction. The drugs Topotecan and Paclitaxel have been mentioned in the context of this disorder. Affiliated tissues include cervix and lymph node, and related phenotypes are homeostasis/metabolism and neoplasm